| Primary |
| Non-small Cell Lung Cancer |
50.0% |
| Pancreatic Carcinoma Metastatic |
50.0% |
|
| Leriche Syndrome |
50.0% |
| Urticaria |
50.0% |
|
| Secondary |
| Glioblastoma |
15.9% |
| Colorectal Cancer Metastatic |
12.4% |
| Colorectal Cancer |
11.4% |
| Drug Use For Unknown Indication |
7.3% |
| Non-small Cell Lung Cancer |
6.3% |
| Product Used For Unknown Indication |
5.7% |
| Breast Cancer |
5.3% |
| Breast Cancer Metastatic |
4.9% |
| Colon Cancer |
4.5% |
| Metastatic Malignant Melanoma |
4.5% |
| Colon Cancer Metastatic |
3.9% |
| Gastric Cancer |
3.3% |
| Rectal Cancer Metastatic |
3.0% |
| Glioblastoma Multiforme |
2.6% |
| Lung Neoplasm Malignant |
2.4% |
| Malignant Melanoma |
1.8% |
| Acral Lentiginous Melanoma Stage Iv |
1.2% |
| Adenocarcinoma Pancreas |
1.2% |
| Lung Adenocarcinoma |
1.2% |
| Neoplasm Malignant |
1.2% |
|
| Pyrexia |
12.3% |
| Thrombocytopenia |
11.0% |
| Pulmonary Haemorrhage |
6.8% |
| Thrombosis |
6.8% |
| Cns Ventriculitis |
5.5% |
| Diarrhoea |
5.5% |
| Neutropenia |
5.5% |
| Acute Myelomonocytic Leukaemia |
4.1% |
| Bronchitis |
4.1% |
| Gastrointestinal Perforation |
4.1% |
| Infection |
4.1% |
| Pulmonary Embolism |
4.1% |
| Urinary Tract Infection |
4.1% |
| Vomiting |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Anaemia |
2.7% |
| Asthenia |
2.7% |
| Breast Cancer Female |
2.7% |
| Candidiasis |
2.7% |
| Dyspnoea |
2.7% |
|
| Concomitant |
| Colorectal Cancer Metastatic |
21.7% |
| Colon Cancer |
17.4% |
| Breast Cancer Metastatic |
15.2% |
| Medulloblastoma |
6.5% |
| Pain |
6.5% |
| Colon Cancer Metastatic |
4.3% |
| Rectal Cancer |
4.3% |
| Adenocarcinoma |
2.2% |
| Chemotherapy |
2.2% |
| Embolism Venous |
2.2% |
| Glioblastoma Multiforme |
2.2% |
| Lung Adenocarcinoma |
2.2% |
| Lung Carcinoma Cell Type Unspecified Recurrent |
2.2% |
| Metastatic Gastric Cancer |
2.2% |
| Non-small Cell Lung Cancer Stage Iiib |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Rectal Adenocarcinoma |
2.2% |
| Rectal Cancer Stage Iii |
2.2% |
|
| Paraesthesia |
8.3% |
| Rash |
8.3% |
| Respiratory Failure |
8.3% |
| White Blood Cells Urine Positive |
8.3% |
| Blood Pressure Immeasurable |
4.2% |
| Bone Marrow Failure |
4.2% |
| Breast Cancer Metastatic |
4.2% |
| Cystoid Macular Oedema |
4.2% |
| Depressed Level Of Consciousness |
4.2% |
| Drug Interaction |
4.2% |
| Hyperammonaemic Encephalopathy |
4.2% |
| Loss Of Consciousness |
4.2% |
| Neutropenia |
4.2% |
| Pneumonia |
4.2% |
| Pneumonitis |
4.2% |
| Renal Failure Acute |
4.2% |
| Second Primary Malignancy |
4.2% |
| Sinus Tachycardia |
4.2% |
| Skin Reaction |
4.2% |
| Thrombotic Thrombocytopenic Purpura |
4.2% |
|
